Founded with the mission to save lives lost to lung cancer, Imidex is an AI-driven medical device company that provides analytical solutions for healthcare providers and insurance companies. The company focuses on leveraging advanced AI technology to detect lung cancer at earlier stages, aiming to reduce the over two million annual fatalities caused by the disease. Their core product involves AI-powered medical devices designed to assist clinicians in early cancer detection, thereby improving patient outcomes.
Notable figures associated with Imidex include CEO Wes Bolsen, who leads a team of world-class data scientists and medical experts dedicated to advancing their technology. The company has made significant strides in the healthcare industry, particularly in the field of oncology, by offering innovative solutions that enhance diagnostic accuracy. Imidex's impact is reflected in its contribution to early cancer detection, potentially saving countless lives and setting new standards in medical diagnostics.
